Richard WilsonSemaglutide was given the go-ahead by the US Food and Drug Administration (FDA) in 2021 for use in the treatment of obesity. It has long been used as a type 2 diabetic medication. The hormone (GLP-1) that the human body naturally produces in the...
Semaglutide was given the go-ahead by the US Food and Drug Administration (FDA) in 2021 for use in the treatment of obesity. It has long been used as a type 2 diabetic medication. The hormone (GLP-1) that the human body naturally produces in the...